Market Overview

Myomo Announces First Adolescent Patients to be Fitted with MyoPro

Share:

Robotic lightweight wearable device empowers young adults with arm
paralysis to live independently, while also reducing healthcare costs

Myomo, Inc., a wearable medical robotics company, has achieved recent
momentum fitting and delivering MyoPro to adolescent users. Approved to
assist young adults suffering from any disease or injury leaving them
with a paralyzed or weakened arm, MyoPro is restoring motion and
functionality to adolescents with conditions such as cerebral palsy,
brachial plexus injury, and more. MyoPro is now being tested on Acute
Flaccid Myelitis ("AFM") patients with promising results.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20181114005049/en/

The first adolescent user to be fitted, Zeke Dees, has regained his
independence after almost a decade of only having use of one arm and
credits his MyoPro device for transforming his life. When he was 8 years
old, he suffered a life-altering ATV accident. At the hospital, doctors
discovered that he suffered a brain injury, a spinal cord injury, and a
brachial plexus injury. Zeke received surgery and significant,
comprehensive therapy and made a remarkable recovery, except for the
brachial plexus injury (BPI) to his shoulder, leaving his arm completely
paralyzed. Subsequently, Zeke had to try to do everything again with one
functional arm.

Use of the MyoPro robotic brace is continuing to expand and is reaching
youth through highly regarded rehabilitation centers including
Easterseals, Shriner's Hospitals and esteemed children's hospitals in
several cities including Cleveland, Boston, Dallas and Cincinnati.
MyoPro has more recently been fitted and delivered to cerebral palsy
patients at some of these facilities with promising early results.

"The brachial plexus is the network of nerves that sends signals from
your spinal cord to your shoulder, arm, and hand. There aren't a lot of
non-invasive, clinical interventions for BPI that produce the same
results as the MyoPro," said Liz May, pediatric occupational therapist
at Shriners Hospital for Children in Chicago. "With the help of the
MyoPro, we are seeing patients drastically improve their range of
motion, spontaneous use, and function of their involved upper extremity,
despite paralysis. This device has allowed my patients to find a new
state of independence, which has completely transformed their outlook on
life."

After his injury, Zeke tried to establish a new sense of normalcy and
considered the reality of spending the rest of his life only having one
functioning arm. Since being fitted for a MyoPro, Zeke has completely
changed his attitude and has been able to resume activities his injury
previously hindered him from doing such as cutting his food, playing
pool and helping with chores around the house.

"My MyoPro device has changed my life dramatically. Not only has it
allowed me to gain my independence back, but it's brought strength back
to my left arm," said Zeke Dees, an adolescent Myomo user. "I got my
brace when I was 17 and I can't imagine life without it. It's already
helped me with the activities of daily living that I couldn't do before."

Paul R. Gudonis, Chairman and CEO of Myomo, said, "Zeke is just one of
many success stories from Myomo patients who have significantly regained
the use of a once paralyzed limb. His personal story is yet another
example of Myomo's commitment to helping restore function in the arms
and hands of individuals who are suffering from the effects of a
neuromuscular disease or injury. We are looking forward to providing
more adolescents a chance to improve their quality of life, just like
Zeke has."

Through patented technology, the MyoPro orthosis can offer individuals
living with a paralyzed arm the opportunity to regain function,
increasing safety and quality of life in the home and reducing
healthcare costs associated with managing upper limb paralysis.

For more information about MyoPro for adolescents, please visit www.myomo.com/adolescents.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers expanded
mobility for those suffering from neurological disorders and upper limb
paralysis. Myomo develops and markets the MyoPro product line. MyoPro is
a powered upper limb orthosis designed to support the arm and restore
function to the weakened or paralyzed arms of patients suffering from
CVA stroke, brachial plexus injury, traumatic brain or spinal cord
injury, ALS or other neuromuscular disease or injury. It is currently
the only marketed device that, sensing a patient's own EMG signals
through non-invasive sensors on the arm, can restore an individual's
ability to perform activities of daily living, including feeding
themselves, carrying objects and doing household tasks. Many are able to
return to work, live independently and reduce their cost of care. Myomo
is headquartered in Cambridge, Massachusetts, with sales and clinical
professionals across the U.S. For more information, please visit www.myomo.com.

Forward Looking Statements

This press release contains forward-looking statements regarding the
Company's future business expectations, including adoption of MyoPro by
adolescent users, which are subject to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements are only predictions and may differ materially from actual
results due to a variety of factors. Our actual results could differ
materially from those anticipated in these forward looking statements
for many reasons, including, without limitation, risks related to
regulatory approval and market acceptance of our products, and the other
risk factors contained in our filings made with the Securities and
Exchange Commission. More information about factors that potentially
could affect Myomo's business and financial results is included in
Myomo's filings with the Securities and Exchange Commission. The Company
cautions readers not to place undue reliance on any such forward-looking
statements, which speak only as of the date made. The Company disclaims
any obligation subsequently to revise any forward-looking statements to
reflect events or circumstances after the date of such statements or to
reflect the occurrence of anticipated or unanticipated events.

View Comments and Join the Discussion!